Page last updated: 2024-10-23

azathioprine and Embolus

azathioprine has been researched along with Embolus in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research Excerpts

ExcerptRelevanceReference
"Azathioprine treatment reduced the aCL titer in the other patient, without fully normalizing it."1.28Primary antiphospholipid syndrome (PAPS). Two case reports and therapeutic implications. ( Engler, H; Lang, B; Peter, HH; Rump, JA, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rump, JA1
Lang, B1
Engler, H1
Peter, HH1

Other Studies

1 other study available for azathioprine and Embolus

ArticleYear
Primary antiphospholipid syndrome (PAPS). Two case reports and therapeutic implications.
    Rheumatology international, 1991, Volume: 10, Issue:6

    Topics: Adolescent; Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Embolism; Fe

1991